Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants

.

Source: Human Vaccines and Immunotherapeutics - August 23, 2022 Category: Allergy & Immunology Authors: Suzanne M. Garland Manjula Anagani Neerja Bhatla Sukanta Chatterjee Sanjay Lalwani Cecil Ross Thomas Group Jianxin Lin Alain Luxembourg Anuj Walia Yingmei Tu Source Type: research